Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul

Hematology

Hospital

All Hospitals

Choose Department

All Branches

Before Noon

Afternoon

You can call our Call Center at 444 4 548 for available appointment slots and information.

Make an Appointment

Areas of Interests

Lymphoma
Acute and Chronic Leukemias
Multiple Myeloma
Thrombocytopenias
Thrombosis
Anemia
Bone Marrow Failure

EDUCATION

Private Culture Science High School
1995-2001, Istanbul University Cerrahpaşa Faculty of Medicine (with honors)
2002-2007 Bakırköy Dr. Sadi Konuk Education and Research Hospital, Internal Medicine
2009-2013 Dr Abdurrahman Yurtarslan Oncology Education and Research Hospital, Hematology

EXPERIENCE

2009- 2013 Ankara Oncology E.A.H Adult Hematology Clinic and Stem Cell Transplantation Unit, Therapeutic Apheresis Laboratory
2013-2015 Gaziantep Dr Ersin Arslan State Hospital (sub-branch DHY)
2015-2016 Gaziantep University (Assoc. Prof.)
2016-2019 Associate Professor, SBÜ Bakırköy Dr Sadi Konuk EAH Internal Medicine Clinic Administrative Manager
2016-2019 Associate Professor, SBÜ Bakırköy Dr Sadi Konuk EAH Hematology Clinic Education and Administrative Manager
2019-2022 Associate Professor, İAÜ Florya Medikalpark Hospital
2019-2022 Head of Internal Medicine Department of IAU Faculty of Medicine
2022 - 2023 Professor, Private Beykent University Faculty of Medicine
Sisli Kolan International Hospital Adult Hematology Clinic and Stem Cell Transplantation Unit, Therapeutic Apheresis Laboratory
2023- present Liv Hospital

A.1 SIRINOGLU DEMIRIZ ITIR,TEKGUNDUZ EMRE,CIVRIZ BOZDAG SINEM,ALTUNTAS FEVZI (2014). Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma. Turkish Journal of Hematology, 31(1), 92-94., Doi: 10.4274/Tjh. 2013.0180, (Control No: 1449937)
A.2 SIRINOGLU DEMIRIZ ITIR,CIVRIZ BOZDAG SINEM,TEKGUNDUZ EMRE,UGUR BILGE,DURGUN GAMZE,KOCUBABA SERİFE,ALTUNTAS FEVZI (2013). Predicting the successful peripheral blood stem cell harvesting. Transfusion and Apheresis Science, 48(3), 411-414., Doi: 10.1016/j.transci.2013.04.028, (Control No: 1449988)
A.3 NAMDAROĞLU SİNEM,TEKGÜNDÜZ EMRE,CIVRİZ BOZDAĞ SİNEM,DURGUN GAMZE,SARICA ABDURRAHMAN,SİRİNOĞLU DEMİRİZ ITIR,KOCUBABA ŞERİFE,İSKENDER GÜLŞEN,KAYIKÇI ÖMÜR, ALTUNTAŞ FEVZİ (2013). Microbial contamination of hematopoietic progenitor cell products. Transfusion and Apheresis Science, 48(3), 403-406., Doi: 10.1016/j. transci.2013.04.026, (Control No: 1450037)
A.4 CİVRİZ BOZDAĞ SİNEM,TEKGÜNDÜZ EMRE,DURGUN GAMZE,SARICA ABDURRAHMAN,ŞİRİNOĞLU DEMİRİZ ITIR,KOÇUBABA ŞERİFE,ALTUNTAŞ FEVZİ (2013). Which regimen is better for stem cell mobilization of lymphoma patients?. Transfusion and Apheresis Science, 48(3), 407-410., Doi: 10.1016/j.transci.2013.04.027, (Control No: 1450121)
A.5 CİVRİZ BOZDAĞ SİNEM,NAMDAROGLU SİNEM,KAYIKÇI ÖMÜR,KAYGUSUZ GÜLŞAH,ŞİRİNOĞLU DEMİRİZ ITIR,ÇINARSOY MURAT,TEKGÜNDÜZ EMRE,ALTUNTAŞ FEVZİ (2013). Diagnosis of large granular lymphocytic leukemia in a patient previously treated for acute myeloblastic leukemia. Hematology Reports, 5(4), 14, Doi: 10.4081/hr.2013.e14, (Control No: 1450170)
A.6 ARSLAN ŞERİFE HÜLYA,ÜYETÜRK ÜMMÜGÜL,TEKGÜNDÜZ EMRE,IRKKAN SULTAN ÇİĞDEM,YÜKSEL MELTEM,ŞİRİNOĞLU DEMİRİZ ITIR,ALTUNTAŞ FEVZİ (2011). Primary breast mucosa- associated lymphoid tissue (MALT) lymphoma transformation to diffuse large B-cell lymphoma: A case report. Turkish Journal of Hematology, Doi: 10.5152/tjh.2011.80, (Control No: 1450229)
A.7 ŞİRİNOĞLU DEMİRİZ ITIR,TEKGÜNDÜZ EMRE,TETİK AYŞEGÜL,KAYIKÇI ÖMÜR,ALTUNTAŞ FEVZİ (2013). Steroid refractory psoriasiform cutaneous graft versus host disease successfully treated by extracorporeal photopheresis: A case report. Transfusion and Apheresis Science, 48(1), 109-111., Doi: 10.1016/j.transci.2012.07.018, (Control No: 1450269)
A.8 YÜKSEL MELTEM,TEKGÜNDÜZ EMRE,SÖNMEZ ÇİĞDEM,TOPÇUOĞLU PERVİN,YURTÇU ARZU,ŞİRİNOĞLU DEMİRİZ ITIR,AYŞEGÜL TETİK,KAYIKÇI ÖMÜR (2012). A feasible shortcut for the mobilization outcome: Steady state CD34 positive hematopoietic stem cells. Transfusion and Apheresis Science, 47(1), 67-75., Doi: 10.1016/j.transci.2012.05.003, (Control No: 1450322)
A.9 TEKGUNDUZ EMRE,YUKSEL MELTEM,CIGDEM ERBAY,ARIBAS BILGIN,OZDILEKCAN CIGDEM, ARSLAN HULYA,KOCUBABA SERİFE,SIRINOGLU DEMIRIZ ITIR,TETIK AYSEGUL,ARDA KEMAL,ALTUNTAS FEVZI (2010). Pandemic 2009 H1N1 Influenza in Patients with Hematopoietic Stem Cell Transplantation and Hematologic Malignancy: Single Center Experience. Oncology, 79(5-6), 409-414., Doi: 10.1159/000320789, (Control No: 1450381)
A.10 ESBAH ONUR,TEKGÜNDÜZ EMRE,ŞİRİNOĞLU DEMİRİZ ITIR,CIVRİZ BOZDAĞ SİNEM,KAYA ALI,TETİK AYŞEGÜL,KAYIKÇI ÖMÜR,DURGUN GAMZE,KOÇUBABA ŞERİFE,ALTUNTAŞ FEVZİ Finding the Optimal Conditioning Regimen for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation: A Retrospective Comparison of Beam and High Dose Ice. TURKISH JOURNAL OF HAEMATOLOGY, Doi: 10.4274/tjh. 2014.0214, (Control No: 1450441)
A.11 ISKENDER GULSEN,CEKEN SABAHAT,SIRINOGLU DEMIRIZ ITIR,ERTEK MUSTAFA,ALTUNTAS FEVZI (2015). Salmonella bacteremia in a patient with aplastic anemia under immunosuppressive treatment. Pamukkale Medical Journal, 9(1), 79-82., Doi: 10.5505/ptd. 2016.60566, (Control No: 2695760)
A12. SIRINOGLU DEMIRIZ ITIR,TEKGUNDUZ EMRE,ALTUNTAS FEVZI (2012). What Is the Most Appropriate Source for Hematopoietic Stem Cell Transplantation? Peripheral Stem Cell/Bone Marrow/Cord Blood. Bone Marrow Research, 2012, 1-5., Doi: 10.1155/2012/834040, (Control No: 1450727))
A13. ERİŞMİŞ BETÜL,ŞİŞMAN MEDINE,SEVER NADİYE,YILMAZ DENİZ,ŞİRİNOĞLU DEMİRİZ ITIR (2018). Etiological evaluation in adult patients presenting with high erythrocyte sedimentation rate. Middle East Medical Journal / Ortadogu Medical Journal . Ortadogu Medical Derg 2019; 11(2): 119-124. https://doi.org/10.21601/ortadogutipdergisi.427550
A.14. ITIR SIRINOGLU DEMIRIZ , A. GULSAN TURKÖZ SUCAK (2020) DISSEMINE INTRAVASCULAR COAGULATION MAY BE THE PRESENTING FEATURE FOR CHRONIC MYELOMONOCYTIC LEUKEMIA .Ist Medicine Fak Derg/ J Ist Faculty Med 2020; 2020;83(4):307-8 .DOI: 10.26650/IUITFD.2019.0052
A. 15. MEHMET HANIFI KAZANCI, MELİH FİLİZ, ITIR SIRINOGLU DEMIRIZ (2020). A 39 YEAR OLD FEMALE PATIENT WITH HYPOFIBRINOGENEMIA DIAGNOSED INCIDENTALLY IN THE PREOPERATIVE PERIOD. Türkiye Clinics Journal of Case Reports.2020;28(2):
A.16. ITIR ŞİRİNOĞLU DEMİRİZ,CEREN GÜMÜŞEL.Is There an Impact of family Support on Treatment in Young Hodgkins lymphoma patients? EURAS Journal of Health-Volume2 Issue 2-December-2021(105-112). DOI: 10.17932/EJOH.2020.022/2021.202

Title Liv

B.1 ŞİRİNOĞLU DEMİRİZ ITIR,TEKGÜNDÜZ EMRE,CIVRİZ BOZDAĞ SİNEM,KOÇUBABA ŞERİFE,GENÇ ZELİHA,DURGUN GAMZE,ÇINARSOY MURAT,TETİK AYŞEGÜL,KAYIKÇI ÖMÜR,ALTUNTAŞ FEVZİ Predicting the successful peripheral blood stem cell (PBSC) harvesting. WORLD APHERESIS CONGRESS 2012 (Oral Presentation), (Control No: 1456433)
B.2 SIRINOGLU DEMIRIZ ITIR, TEKGUNDUZ EMRE, DURGUN GAMZE, TETIK AYSEGUL, GENC ZELIHA, CIVRIZ BOZDAG SINEM, KOCUBABA SERİFE, SARICA ABDURRAHMAN, KILINC ALI, ALTUNTAS FEVZI. Bacterial contamination of hematopietic stem cell products during collection and cryopreservation. WORLD APHERESIS CONGRESS 2012 (Oral Presentation), (Control No: 1456495)
B.3 CİVRİZ BOZDAĞ SİNEM,ŞİRİNOĞLU DEMİRİZ ITIR,TEKGÜNDÜZ EMRE,YURTÇU ARZU,KAYIKÇI ÖMÜR,TETİK AYŞEGÜL,NAMDAROGLU SİNEM,BİLGE UĞUR,DURGUN GAMZE,ALTUNTAŞ FEVZİ .Systemic chemotherapy and G-CSF combination method for the hematopoietic stem cell mobilization. WORLD APHERESIS CONGRESS 2012 (Oral Presentation), (Control No: 1456540)
B.4 SIRINOGLU DEMIRIZ ITIR, TEKGUNDUZ EMRE, CIVRIZ BOZDAG SINEM, DURGUN GAMZE, GENC ZELIHA, KOCUBABA SERİFE, KAYIKCI OMR, NAMDAROGLU SINEM, BILGE UĞUR, ALTUNTAS FEVZI . Pretransplant specific comorbidity index as an outcome predictor for hematopoietic stem cell transplantation patients: single center experience. WORLD APHERESIS CONGRESS 2012 (Poster), (Control No: 1456593)
B.5 EMRE TEKGÜNDÜZ,ŞİRİNOĞLU DEMİRİZ ITIR,ÇİVRİZ BOZDAĞ SİNEM,ÖZKAYMAK AYŞEGÜL,UÇAR İCLAL,FULYA ERTEM,KAYIKÇI ÖMÜR,TETİK AYŞEGÜL,ÇINARSOY MURAT,ALTUNTAŞ FEVZİ. Is it possible to predict relaps after allogeneic stem cell transplantation via bone marrow chimerism analysis?. WORLD APHERESIS CONGRESS 2012 (Poster), (Control No: 1456654)
B.6 SIRINOGLU DEMIRIZ ITIR, KOCUBABA SERİFE, TEKGUNDUZ EMRE, CIVRIZ BOZDAG SINEM, TETIK AYSEGUL, DURGUN GAMZE, GENC ZELIHA, CINARSOY MURAT, KAYIKCI OMR, ALTUNTAS FEVZI . Common adverse reactions during hematopoietic stem cell infusion. WORLD APHERESIS CONGRESS 2012 (Poster), (Control No: 1456700)
B.7 TEKGUNDUZ EMRE, AKPINAR SEVAL, CİVRİZ BOZDAĞ SİNEM, TETİK AYŞEGÜL, KOCUBABA ŞERİFE, ÇINARSOY MURAT, DURGUN GAMZE, NAMDAROĞLU SİNEM, KAYIKÇI ÖMÜR, BILGE UĞUR, ŞİRİNOĞLU DEMİRİZ ITIR, ALTUNTAŞ FEVZİ. Effectiveness of defibrotide in the prevention of VOD among patients receiving allogeneic hematopoietic cell transplantation: a retrospective single center experience. ASH annual meeting 2012 (Abstract paper), (Control No: 1459750)
B.8 ALTUNTAŞ FEVZİ, CİVRİZ BOZDAĞ SİNEM, ŞİRİNOĞLU DEMİRİZ ITIR, TETİK AYŞEGÜL, KAYIKÇI ÖMÜR, ÇINARSOY MURAT, NAMDAROĞLU SİNEM, BILGE UĞUR, EMRE TEKGÜNDÜZ (2013). BEAM or ICE ?. EBMT 2013 TANDEM MEETİNG (Poster), (Control No: 2696390)
B.9 TETİK AYŞEGÜL,CİVRİZ BOZDAĞ SİNEM,TEKGÜNDÜZ EMRE,ŞİRİNOĞLU DEMİRİZ ITIR,KAYIKÇI ÖMÜR,ÇINARSOY MURAT,NAMDAROĞLU SİNEM,BİLGE UĞUR,ALTUNTAŞ FEVZİ (2013). Mesenchymal stem cell transplantation for steroid refractory graft-versus-host disease; single centre experience. EBMT 2013 (Poster), (Kontrol No: 2696444)
B10.GULCICEK GAMZE,SIRINOGLU DEMIRIZ ITIR (2019). Hematuria and hematochezia; could it be the first admission to a case of multipl myeloma?. ICLLM 2019 (Poster). P-057
B11. SIRINOGLU DEMIRIZ ITIR, KAYA NAZMIYE ELIF,HINDILERDEN FEHMI,YEGEN GULCIN,KARAOGLAN CAGLA (2019). The very rare mast cell leukemia presenting with anasarca edema. ICLLM 2019 (Poster).P-043
B12. HINDILERDEN FEHMI,YUCEL MEHMET HALUK,SIRINOGLU DEMIRIZ ITIR (2019). Successful treatment of acute lymphoblastic leukemia during pregnancy resulting in a safe delivery: case report. ICLLM 2019 (Poster). P-036
B13. CEREN GUMUSEL, ITIR SIRINOGLU DEMIRIZ. A Case of Hodgkin Lymphoma Presented with the Symptoms of adult Still Disease. AHOS 2019 (Poster) P21.
B14. ITIR SIRINOGLU DEMIRIZ, ISIL OZBAS TEVETOGLU, BULENT UYANIK. Diagnosing Niemann-Pick Type B by Bone Marrow Biopsy. AHOS 2019 (Poster) P24.
B15. KUBRA SAYIM, CEREN GUMUSEL, ITIR SIRINOGLU DEMIRIZ, FEHMI HINDILERDEN. Analysis of Demographic Data and Laboratory Values of Trombotic Microangiopathy Cases: A single-center experience. AHOS 2020 (Poster) P7.
B16. EMRE AKAR, ATAKAN TEKINALP, GOZDE NEZAHAT GENC, ITIR SIRINOGLU DEMIRIZ. Comparison of IPSS, IPSS-R and WPSS risk Groups on Darbepoetin response in Myelodysplastic Syndrome. AHOS 2021 ( Oral Presentation) 14.

D. Articles published in national refereed journals:

D.1 SIRINOGLU DEMIRIZ ITIR, NAMDAROGLU SINEM, ALTUNTAS FEVZI (2013). Primary Central Nervous System Lymphomas. TURKISH CLINICS, (Control No: 1450626)
D.2 KUTLU MEHMET, OSMAN NESRIN, SIRINOGLU DEMIRIZ ITIR, CILTAS AYDIN, DAGTEKIN EMINE NUR, EREN YUSUF, TASKALE MUSTAFA GURKAN, KUMBASAR ABDULBAKI, GURSEL OKAN, ACIKGOZ OZGUR, BASAK MESUT (2005). Castleman Case Report. BAKIRKÖY MEDICAL JOURNAL (Bakirkoy Medical Journal), (Control No: 1450708)
D.3.. YAVUZ ERİŞMİŞ GÜL, ŞİRİNOĞLU DEMİRİZ ITIR (2021). Use of Biomarkers in Clinical Practice During COVID -19. Definition and Importance of Biomarkers. TURKEY CLINICS COVID-19 2021;p 1-3.

E. Papers presented at national scientific meetings and published in proceedings books:

E.1 ARSLAN ŞERİFE HÜLYA, KURDAL MEVLÜDE, KOCAKAPLAN ELİF, SARICA ABDURRAHMAN, KAYIKÇI ÖMÜR, ÇINARSOY MURAT, TETİK AYŞEGÜL, BULUT MESUDİYE, ŞİRİNOĞLU DEMİRİZ ITIR, TEKGÜNDÜZ EMRE, YÜKSEL MELTEM, ALTUNTAŞ FEVZİ Platelet Apheresis Donor Characteristics. 6. National Apheresis Congress 2011, (Control No: 1458765)
E.2 ÇINARSOY MURAT,ARSLAN ŞERİFE HÜLYA,TETİK AYŞEGÜL,KAYIKÇI ÖMÜR,ŞİRİNOĞLU DEMİRİZ ITIR,SARICA ABDURRAHMAN,KOCAKAPLAN ELİF,NAZLIMLAR MUSTAFA,TEKGÜNDÜZ EMRE,YÜKSEL MELTEM,ALTUNTAŞ FEVZİ. Therapeutic Leukopheresis in Leukostasis Secondary to Acute Leukemia. 6.National Apheresis Congress 2011, (Control No: 1458815)
E.3 YÜKSEL MELTEM, TEKGÜNDÜZ EMRE, ATAY ÇİĞDEM, YURTCU ARZU, ŞİRİNOĞLU DEMİRİZ ITIR, KAYIKÇI ÖMÜR, BULUT MESUDİYE, ÇINARSOY MURAT, TOPÇUOĞLU PERVİN, ALTUNTAŞ FEVZİ CAN BASAL CD34 NUMBER PREDICT MOBILIZATION SUCCESS?. 6.NATIONAL APHERESIS CONGRESS 2011, (Control No: 1458855)
E.4 ARSLAN ŞERİFE HÜLYA, ÇINARSOY MURAT, KAYIKÇI ÖMÜR, TETİK AYŞEGÜL, SARICA ABDURRAHMAN, KOCAKAPLAN ELİF, BULUT MESUDİYE, ŞİRİNOĞLU DEMİRİZ ITIR, TEKGÜNDÜZ EMRE, YÜKSEL MELTEM, ALTUNTAŞ FEVZİ DONOR PLATELET APHERESIS: SINGLE DOSE? DOUBLE DOSE?. 6.NATIONAL APHERESIS CONGRESS 2011, (Control No: 1458886)
E.5 ŞİRİNOĞLU DEMİRİZ ITIR,TEKGÜNDÜZ EMRE,AKARSU MENTEŞ FADIME,BULUT MESUDİYE,KAYIKÇI ÖMÜR,ÇINARSOY MURAT,YÜKSEL MELTEM,ALTUNTAŞ FEVZİ LYMPHOMA FOLLOWING CHRONIC MYELOID LEUKEMIA: A RARE SECONDARY MALIGNANCY.. 37.NATIONAL HEMATOLOGY CONGRESS 2011, (Control No: 1458920)
E.6 ŞİRİNOĞLU DEMİRİZ ITIR,TEKGÜNDÜZ EMRE,KOCUBABA ŞERİFE,ÇINARSOY MURAT,KAYIKÇI ÖMÜR,BULUT MESUDİYE,YÜKSEL MELTEM,ALTUNTAŞ FEVZİ SYSTEMIC CHEMOTHERAPY AND PERIPHERAL STEM CELL MOBILIZATION WITH G-KUF. 37TH NATIONAL HEMATOLOGY CONGRESS 2011, (Control No: 1458957)
E.7 BİLGE UĞUR,CIVRİZ BOZDAĞ SİNEM,EMRE TEKGÜNDÜZ,MURAT ÇINARSOY,ÖMÜR KAYIKÇI,SİNEM NAMDAROĞLU,ŞİRİNOĞLU DEMİRİZ ITIR,AYŞEGÜL TETİK,ALTUNTAŞ FEVZİ NELARABINE EXPERIENCE IN RELAPSED/REFRACTORY T-ALL/T LYMPHOBLASTIC LYMPHOMA CASES. 38th NATIONAL HEMATOLOGY CONGRESS, (Control No: 1459034)
E.8 AYŞEGÜL TETİK, CİVRİZ BOZDAĞ SİNEM, EMRE TEKGÜNDÜZ, ŞİRİNOĞLU DEMİRİZ ITIR, MURAT ÇINARSOY, BILGE UĞUR, SİNEM NAMDAROĞLU, ALTUNTAŞ FEVZİ EXPERIENCE OF CLOFARABINE/ARA-C IN RELAPSED/REFRACTORY AML CASES. 38.NATIONAL HEMATOLOGY CONGRESS, (Control No: 1459064)
E.9 GÜLŞEN İSKENDER, CİVRİZ BOZDAĞ SİNEM, EMRE TEKGÜNDÜZ, ŞİRİNOĞLU DEMİRİZ ITIR, CİHAT OGAN, MURAT ÇINARSOY, AYSEGÜL TETİK, ÖMÜR KAYIKÇI, BILGE UĞUR, SİNEM NAMDAROĞLU, ALTUNTAŞ FEVZİ LAMIVUDINE PROPHYLAXIS IN HEPATITIS B CARRIER PATIENTS DIAGNOSISED WITH CANCER. 38.NATIONAL HEMATOLOGY CONGRESS, (Control No: 1459127)
E.10 TEKGÜNDÜZ EMRE,ŞİRİNOĞLU DEMİRİZ ITIR,KOÇUBABA ŞERİFE,KAYIKÇI ÖMÜR,BULUT MESUDİYE,ÇINARSOY MURAT,YÜKSEL MELTEM,ALTUNTAŞ FEVZİ PERIPHERAL STEM CELL MOBILIZATION WITH PLERIXAFOR IN LYMPHOMA CASES: A SINGLE CENTER EXPERIENCE. 37. NATIONAL HEMATOLOGY CONGRESS, (Control No: 1459150)
E.11 GÜLŞEN İSKENDER,OĞAN CİHAT,SEMA BATI,AYLA YENİGÜN,ŞİRİNOĞLU DEMİRİZ ITIR,MURAT ÇINARSOY,TEKGÜNDÜZ EMRE,YÜKSEL MELTEM,ALTUNTAŞ FEVZİ LAMİVUDINE PROPHYLAXIS IN HEPATITIS B CARRIERS WITH HEMATOLOGICAL MALIGNANCY. 37TH NATIONAL HEMATOLOGY CONGRESS, (Control No: 1459194)
E.12 ÖMÜR KAYIKÇI,ŞİRİNOĞLU DEMİRİZ ITIR,MESUDIYE BULUT,MURAT ÇINARSOY,EMRE TEKGÜNDÜZ,YÜKSEL MELTEM,ALTUNTAŞ FEVZİ IS VİGEPP A GOOD OPTION AS A SALVAGE TREATMENT IN RELAPSED AND REFRACTORY LYMPHOMA? 37TH NATIONAL HEMATOLOGY CONGRESS, (Control No: 1459228)
E.13 GÜLŞEN İSKENDER,OĞAN CIHAT,MÜFİDE ÇİMENTEPE,ECE BİLEN DİRİM,ŞİRİNOĞLU DEMİRİZ ITIR,MURAT ÇINARSOY,NURAN AKAY,YİĞİT YEŞİM,HÜRÜYE ÖZEN,EMRE TEKGÜNDÜZ,YÜKSEL MELTEM CENTRAL VENOUS CATHETER-RELATED BLOOD STREAM INFECTIONS IN PATIENTS WITH HEMATOLOGIC MALIGNACY. 37.NATIONAL HEMATOLOGY CONGRESS, (Control No: 1459286)
E.14 ÇINARSOY MURAT,ŞİRİNOĞLU DEMİRİZ ITIR,ÖZEN MEHMET,TEKGÜNDÜZ EMRE,ALTUNTAŞ FEVZİ (2015). Comparison of Dana-Farber and Hyper CVAD protocols in acute lymphoblastic leukemia patients under the age of forty. 41.NATIONAL HEMATOLOGY CONGRESS, (Control No: 2696028)
E.15 YILMAZ MEHMET,ŞİRİNOĞLU DEMİRİZ
E.18 ÇINARSOY MURAT,GEMİCİ ALİ İHSAN,ŞİRİNOĞLU DEMİRİZ ITIR,TEKGUNDUZ EMRE,ALTUNTAŞ FEVZİ (2015). A Richter transformation case using rituximab,ibrutinib and bortezomib combination. 41st NATIONAL HEMATOLOGY CONGRESS, (Control No: 2696070)
E.19 PEPEDİL TANRIKULU FUNDA,ŞİRİNOĞLU DEMİRİZ ITIR,TUNCER MEHMET TAMER,SARI İBRAHİM, YILMAZ MEHMET (2015). A case with diffuse large B cell lymphoma as a primary pancreatic tumor. 41st NATIONAL HEMATOLOGY CONGRESS, (Control No: 2696099)
E.20 SEYYAR MUSTAFA, SIRINOGLU DEMIRIZ ITIR, BAY ALI, OKYAR BURAK, OKAN VAHAP, PEHLIVAN MUSTAFA, YILMAZ MEHMET (2015). Granulocyte transfusion therapy; Our experience with 5 patients. 10th NATIONAL APHERESIS CONGRESS, (Control No: 2715949)
E.21 OKYAR BURAK, SIRINOGLU DEMIRIZ ITIR, SEYYAR MUSTAFA, OKAN VAHAP, PEHLIVAN MUSTAFA, OZASLAN IBRAHIM, YILMAZ MEHMET (2015). Therapeutic plasmapheresis application in multiple myeloma cases: Single center experience. 10.NATIONAL APHERESIS CONGRESS, (Control No: 2715983)
E22 Şirinoğlu Demiriz Itır, Erişmiş Betül, Midi Kürsat Firuze, Kürsat Hakan, Fehmi from Turkeys, Osmanbaşoğlu Emre (2017). Prevalence and Etiological Classification of Thrombocytopenia in Pregnant Women; Single center experience. 43.National Hematology Congress, (P-073)
E23 Şirinoğlu Demiriz Itır, Şahin Tunahan, Fehmi from Turkeys, Osmanbaşoğlu Emre, Ördekçi Seyhan (2017). A Very Rare Non-Langerhans Histiocytic Disease; Erdheim-Chester Disease Case Report. 43rd National Hematology Congress, (P-131)
E24 Kazancı Mehmet Hanifi, Erdoğdu Buğrahan, Şirinoğlu Demiriz Itır, Osmanbaşoğlu Emre, Fehmi from Turkey, Yılmaz Deniz, Harmankaya Özlem, Okuturlar Yıldız; Adult Atypical Acute Leukemia and Malaria Coexistence. (2017). 43rd National Hematology Congress, (P-138)
E25. Şirinoğlu Demiriz Itır, Özdemir Bahar, Fehmi from Turkey, Osmanbaşoğlu Emre, Okuturlar Yıldız (2017). How effectively do we screen for hereditary thrombophilia? Single center experience. 43rd National Hematology Congress, (P-194)
E26. Firuze Midi Kursat, Hakan Kursat, Gamze Gülçiçek, Itır Şirinoğlu Demiriz. Iron Deficiency Anemia in Beta Thalassemia Carriers. EHOK 2019 (Oral Presentation) S6.
E27. Mehmet Hanifi Kazancı, Itır Şirinoğlu Demiriz, Denis Sabriye Bozer. The relationship between JAK2V617F mutation allele load and demographic characteristics, phlebotomy count and complete blood count parameters in BCR/ABL negative CMPH cases. EHOK 2019 (Oral Presentation) S7. First prize.
E28. Ceren Gümüşel, Itır Şirinoğlu Demiriz, Süheyla Apaydın, Mehmet Sar, Mehmet Hurşitoğlu. A young, non-secretory multiple myeloma case presenting with hypercalcemia, acute renal failure and plasmablastic histopathology. EHOK 2019 (Poster) P10.
E29. Gizem Kaynar, Itır Şirinoğlu Demiriz. A myeloma case presenting with dramatic and unusual extramedullary involvement. EHOK 2019 (Poster) P21.
E30. Sevde Yazıcı, Itır Demiriz, Nigar Hüseynzade. Variable distribution of Platelet Apheresis Donors during the year: Single center data. EHOK 2020 (Oral presentation) P4.
E31. Mehmet Hanifi Kazancı, Emre Akar, Faika Hazal Tüper, Itır Şirinoğlu Demiriz. Evaluation of Laboratory, Culture and Treatment Stages of Febrile Neutropenia Attacks in Patients Hospitalized in Hematology Clinic. EHOK 2020 (Oral Presentation) P9.
E32. Melis Özyazanlar, Gözde Nezahat Genç, Emre Akar, Itır Şirinoğlu Demiriz. SBÜ Bakırköy Dr Sadi Konuk EAH Pegylated-Interferon Alfa Experience in Essential Thrombocythemia Patients. EHOK 2020 (Poster) P19.
E33. Emre Akar, Itır Şirinoğlu Demiriz, Ayşenur Arslan, Güray Saydam. Does BCR-ABL provide more information than IS value in the evaluation of Sokal scoring and treatment response in patients with Chronic Myeloid Leukemia? EHOK 2021 (Oral Presentation) S16.
E34. Ceren Gümüşel, Kübra Sayım, Emre Akar, Itır Şirinoğlu Demiriz, Fehmi Hindilerden. Evaluation of Thrombotic Thrombocytopenic Purpura Cases: 5-year single center experience. EHOK 2021 (Poster) P1.
E35. Emre Akar, Itır Şirinoğlu Demiriz. A Fatal Non-Hodgkin Lymphoma Complication: Common Carotid Artery Erosion and Rupture. EHOK 2022 (Oral Presentation). S13.
E36. Gamze Gülçiçek, Emre Akar, Fehmi Hindilerden, Itır Şirinoğlu Demiriz. How resistant can a myeloma case be? 6th International Experimental Hematology Congress. April 19-21, 2019 (Oral presentation)
E37. Mehmet Hanifi Kazancı, Itır Şirinoğlu Demiriz. Biclonal CML case. 6th International Experimental Hematology Congress. April 19-21, 2019 (Oral presentation)
E38. Ceren Gümüşel, Itır Şirinoğlu Demiriz, Fehmi Hindilerden. Young, pregnant and ALL: How should we approach? 6th International Experimental Hematology Congress. April 19-21, 2019 (Oral presentation)

ORAL PRESENTATION/ CONGRESS SPEECH

Peripheral stem cell mobilization with Plerixafor in lymphoma cases: Single center experience; 37th national hematology congress, 2011; Ali İrfan Emre Tekgündüz, Itır Şirinoğlu Demiriz, Şerife Koçubaba, Ömür Kayıkçı, Mesudiye Bulut, Murat Çınarsoy, Meltem Yüksel, Fevzi Altuntaş. Ankara Dr.Abdurrahman Yurtarslan Oncology Training and Research Hospital, Adult hematology and KİT unit, Ankara
Predicting the successful peripheral blood stem cell (PBSC) harvesting. Demiriz IS, Tekgunduz AIE, Bozdag SC, Kocubaba S, Genc Z, Durgun G, Cinarsoy M, Tetik A, Kayikci O, Altuntas F. Transfus Apher Sci. 2012; 47 (suppl 1): S3. (World Apheresis Congress- oral presentation in English)
Recent developments in the treatment of iron deficiency anemia. Anadolu Group Education Meeting. (2013)
Approach to the patient with anemia. TAEDER 2nd Internal Medicine Academy. (2018)
Practical approach to thrombocytopenia. SBU Internal Medicine Congress, Istanbul 2018
Diagnosis and treatment of aplastic anemia. SBU Hematology Symposium, Istanbul October 2018 (Congress secretary duty and speaker and session chair)
“My Amyloidosis Patient Wing” presentation. THD 12th Postgraduate Hematology Education Course, 30.10.2018, Antalya
Transfusion and Stem Cell Transplantation Nursing, Transfusion Session. 1st Hematological Rare Diseases Congress. Session Chair. (8-10 February 2019)
The Place of Monoclonal Antibodies in the Treatment of AML. Speaker in AML session of 2nd Hematological Rare Diseases Congress (February 7-10, 2019)
B-cell Aggressive Lymphomas in 2019. Speaker in Lymphoma Session of 5th EGE Hematology Oncology Congress (March 15-17, 2019)
Pathophysiological Treatment Approach in ITP. Speaker in Bleeding Diathesis Session of 6th Mediterranean Hematology Symposium (April 5-17, 2019)
Neutropenia and thrombocytopenia management. TAEDER 3rd Internal Medicine Academy (April 4-7, 2019)
When to stop and when to treat in follicular lymphoma. 6th International Experimental Hematology Congress (April 19-21, 2019)
Treatment of benign platelet disorders, 6th Aegean hematology oncology Symposium (October 3-6, 2019)
45-year of age patient with hypoplastic MDS, case presentation, 7th Aegean Hematology Oncology Symposium (September 17-20, 2020)
MM: How to decide on patient suitability for transplantation, is it necessary in today's conditions? , MM session, Hematology Specialist Association National Congress (December 12-15, 2020)
Targeted therapies in AML: 2021 update, III. Hematological Rare Diseases Congress (December 25-27, 2020)
Autologous Transplantation in Myeloma, The most appropriate time? , 13th National Bone Marrow Transplantation and Cellular Therapies Congress, Multiple Myeloma session (April 2-3, 2021)
Is consolidation important in acute leukemia?, 9th Aegean Hematology Oncology Congress, acute leukemia session (March 18-20, 2021)
All patients with intermediate-risk AML must be transplanted, Acute Leukemias session, 8th Aegean Hematology Oncology Symposium (September 16-19, 2021)
III. Hematology Education and Research Congress, Stem Cell Transplantation Nursing Course, session chairman (September 16-19, 2021)
NPM1 Mutated AML: from bench to bedside, Hematology Specialist Association 2nd National Congress, AML session (October 8-10, 2021)
11th Istanbul Internal Medicine Clinics Meeting, Hematology Panel Session Chair, November 13, 2021
A Fatal Non-Hodgkin Lymphoma Complication: Common Carotid Artery Erosion and Rupture, 10th Aegean Hematology Oncology Congress (March 17-19, 2022)
Therapeutic approaches in high-risk MDS; VIIIth International Experimental Hematology Congress (September 09-11, 2022)
The reasons to favor standard intensive chemotherapy for older fit AML patients. 9th Aegean Hematology Oncology Symposium. (September 15-18, 2022)
Plasma Cell Diseases Session: Diagnosis and Treatment in MGRS. 48th National Hematology Congress (November 2-5, 2022) Thesis Advisors
F.1. Evaluation of immune response in patients with iron deficiency anemia by lymphocyte subgroup analysis; Internal Medicine Assistant thesis advisor
F.2. Relationship between endoscopic biopsy findings and patient anemia depth and iron parameters during diagnosis and treatment in patients with dyspeptic complaints (nausea, heartburn, reflux, etc.) and/or iron deficiency, treatment response analysis, Internal Medicine Assistant thesis advisor
F.3. Comparison of survival effects among demographic characteristics, treatment differences and molecular prognostic markers in newly diagnosed Multiple Myeloma patients. Internal Medicine Assistant Thesis Advisor
F.4. Investigation of the effect of JAK-2 V617F allele load on hematological parameters and spleen size response during treatment in patients with Philadelphia negative chronic myeloproliferative neoplasia (CMPN). Internal Medicine Assistant Thesis Advisor

J. BOOK CHAPTER WRITER AND TRANSLATION EDITOR

Diabetes Mellitus Handbook
Braunwald Heart Diseases
Endocrine Secrets
Rheumatology Secrets
Harrison Internal Medicine Principles
Harrison Board Review
Topol's Cardiology Handbook
Cardiology, Self-Assessment Rosen,Sharma,Oakley
Haematopoietic Stem Cell Mobilization and Apheresis Handbook
Bethesda Handbook of Clinical Oncology
Hematology at a Glance Fourth edition
Turkish Hematology Association Multiple Myeloma National Guide, author, 2019-2020
Textbook of Multiple Myeloma and Other Plasma Cell Neoplasms, Chapter 6, Other Complications of Multiple Myeloma, chapter author
Symptoms and Clinical Situations, SBU Internal Medicine Book, Chapter 84, Lymphadenopathy, chapter author
Internal Medicine Current Diagnosis and Treatment, Plasma Cell Diseases, chapter author